QRL-201 - Dose 5 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
2筋萎縮性側索硬化症1

2. 筋萎縮性側索硬化症


臨床試験数 : 645 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05633459
(ClinicalTrials.gov)
December 16, 202221/11/2022A Study Evaluating the Safety and Tolerability of QRL-201 in ALSA Multi-Center, Randomized, Double-Blind Placebo Controlled Multiple-Ascending Dose Study to Evaluate the Safety and Tolerability of QRL-201 in Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisDrug: QRL-201 - Dose 1;Drug: QRL-201 - Dose 2;Drug: QRL-201 - Dose 3;Drug: QRL-201 - Dose 4;Drug: QRL-201 - Dose 5;Drug: QRL-201 - Dose 6;Drug: QRL-201 - Dose 7;Drug: QRL-201- Dose 8QurAlis CorporationNULLRecruiting18 Years80 YearsAll64Phase 1Canada